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Treatment Options for Obstructive Sleep Apnea
Abstract
Obstructive sleep apnea (OSA) is sleep-disordered breathing caused by the collapse of the upper airway.
Because anatomical abnormalities of the narrow upper airway are undoubtedly the most critical cause of
OSA, the available treatment methods for OSA mostly focus on these anatomical problems. The collapse
of the respiratory tract is associated with different levels of upper airway obstruction. The obstruction of
the airway can be divided into three parts: the nasal cavity, retropalatal region, and retrolingual region.
This article summarizes some common OSA treatment methods, their underlying theories, and their
effect on the upper airway.
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Obstructive sleep apnea (OSA) is sleep-disordered breathing caused by the collapse of the upper airway.
Because anatomical abnormalities of the narrow upper airway are undoubtedly the most critical cause of OSA,
the available treatment methods for OSA mostly focus on these anatomical problems.
The collapse of the respiratory tract is associated with different levels of upper airway obstruction. The
obstruction of the airway can be divided into three parts: the nasal cavity, retropalatal region, and retrolingual
region. This article summarizes some common OSA treatment methods, their underlying theories, and their
effect on the upper airway. (Taiwanese Journal of Orthodontics. 32(1): 17-24, 2019,2020)
Keywords: obstructive sleep apnea; oral appliance; maxillary expansion; Powell-Riley surgical protocol.

INTRODUCTION

Diagnosis

Obstructive sleep apnea (OSA) is a sleep disorder
where breathing repeatedly stops or weakens because of
upper airway collapse during sleep. This airway collapse
results from anatomical abnormalities and low pharyngeal
1

dilator muscle tone during sleep. Upper airway collapse
during sleep results in snoring, sleep fragmentation, and
2

hypoxemia, leading to symptoms such as excessive
daytime sleepiness, inattention, memory loss, anxiety, and
3

depression. Thus, it may increase the incidence of car

The diagnosis of OSA is based on physical examinations,
a sleep test, and the medical history of a patient.
Polysomnography (PSG) is the standard sleep
test for OSA. It involves electroencephalography,
e l e c t r o o c u l o g r a p h y, c h i n e l e c t r o m y o g r a p h y,
electrocardiography, and measurements of the patient’s
2

airflow, oxygen saturation, respiratory effort, and heart rate.

The most crucial piece of information in PSG is the
Apnea-Hypopnea Index (AHI), defined as the number of

accidents. OSA may also lead to heart disease, high blood

apneas or hypopneas per hour of sleep. If the AHI> 5 for

pressure, stroke, or type 2 diabetes. This makes OSA a

a patient who has signs and symptoms of disturbed sleep,

serious threat to the health and quality of life of patients.

the diagnosis of OSA is confirmed.

4

2

Received: August 19, 2019 Revised: April 6, 2020 Accepted: April 16, 2020
Reprints and correspondence to: Yu-Chuan Tseng, DDS, MDS, PhD
	Department of Orthodontics, Kaohsiung Medical University Hospital, No. 100, Shih-Chuan 1st
Road, San-Ming District, Kaohsiung 80708, Taiwan.
Tel: +886-7-3121101 ext. 7009
Fax: +886-7-3221510
E-mail: yct79d@seed.net.tw

Taiwanese Journal of Orthodontics. 2020, Vol. 32. No. 1
10.30036/TJO.202003_32(1).0002

17

Hsieh SC, Chou ST, Tseng YC

The severity classification of OSA, defined by the

palate and may increase the risk and severity of OSA.

8,9,10

American Academy of Sleep Medicine, is as follows: mild

Significant OSA is present in 40% of obese individuals

(if 5 ≤ AHI < 15), moderate (if 15 ≤ AHI ≤ 30), and severe

and 70% of OSA patients are obese.

(if AHI > 30).

2

11

Weight loss is an effective method for the nonsurgical treatment of OSA.

Site of upper airway obstruction
PSG can diagnose the severity of OSA, but it cannot
distinguish the obstruction site in OSA. Oral examination,

5

fiberopticnasopharyngolaryngoscopy (with Müller’s
6

12

Diet modification,

medication, and surgical weight loss can improve the
condition of patients with OSA.

12,13

Diet control and

weight loss of 9%–20% can reduce AHI by 30%–75%.

14

maneuver), lateral cephalometric analysis, computed

Continuous positive airway pressure

tomography, and magnetic resonance imaging should be

Continuous positive airway pressure (CPAP) is the

7

first-line treatment for moderate to severe OSA.

used to identify the site of obstruction.
The potential site of upper airway obstruction can
be divided into three main areas: nasal cavity, retropalatal
7

region, and retrolingual region (Table 1).

The severity of OSA and the location of airway
obstruction must be confirmed prior to treatment to
establish a treatment baseline and make a reasonable
treatment plan.

2,15,16,17

It

provides pressure to open the airway that collapses when
sleeping, which can effectively reduce AHI and maintain
the blood oxygen concentration in the patient.

18,19,20

It is

largely proven to be efficacious in reducing sleepiness,
21

blood pressure, and cardio/cerebrovascular risk.

CPAP is suitable for patients with mild, moderate,
and severe OSA and is effective regardless of the site of
22

airway obstruction. When patients use CPAP, they can

Treatment of OSA

eliminate apneas and hypopneas, and the blood oxygen

Reduce the body weight

20,23

Obesity is a significant risk factor for OSA.
Excessive adipose tissue in the upper respiratory tract
accumulates in the tongue, pharyngeal wall, and soft

concentration can be maintained in the normal range.

However, adherence to CPAP has always been a
19

problem. On average, 10.7% of patients cannot tolerate

24

CPAP. The average duration of nighttime use is only 4.7 h.

Table 1. The potential sites of upper airway obstruction and their causes.

18

Obstruction site

Cause

Nasal

septal deviation, turbinate hypertrophy, alar collapse or
sinonasal masses

Retropalatal

posteriorly elongated palate and uvula, tonsil and adenoid
hypertrophy

Retrolingual

macroglossia, retrognathia and micrognathia, inferior
displacement of hyoid
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The overall CPAP non-adherence rate was reported to be

OSA by correcting a high-arched palate. It could extend the

34.1%, which may not allow CPAP treatment to reach the

expansion to the nasal cavity, reduces nasal obstruction, and

therapeutic threshold, thus casting a doubt on its efficacy.

improves tongue position in oral breathing.

24

Maxillary expansion for pediatric OSA

Oral appliances
The two main types of oral appliances (OAs)
are mandibular repositioning appliances and tongue
retaining devices.

2

The function of an OA is to advance the lower jaw or
tongue to help opening the upper airway; in essence, OA
is more effective for patients with prevalent retrolingual
obstruction and retrognathia.

25,26,27

On the other hand,

nasal obstruction may reduce patients’ tolerance to the
OA and have a negative influence on treatment response.

Pediatric OSA is classified as mild if 1 ≤ AHI < 5,
36

moderate if 5 ≤ AHI ≤ 10, and severe if AHI > 10. The
most common cause of pediatric OSA is the enlargement
37,38

of tonsils and/or adenoids.

The modalities of treatments

for pediatric OSA are adenotonsillectomy, CPAP, weight
36,39,40

loss, and medications.

Rapid maxillary expansion (RME) is another option
for treating pediatric OSA. RME stretches and widens
the maxilla and nasal floor by distraction osteogenesis to
41,42

Increased nasal resistance is associated with a higher

reduce nasal obstruction.

proportion of oral breathing during sleep.

adolescents with a narrow palate and dental crossbite.

28

Because

It is suitable for children and

42,43

the mouth opening may be limited by OAs, mouth

RME creates more space for the tongue to raise, thus

breather (nasal obstruction) tend not to tolerate the OA.

indirectly enlarging the pharyngeal airway. After RME

Higher nasal resistance also associated with pharyngeal

treatment, the mean reduction in AHI was 6.86 events/ h.

and lingual collapse, reduce the effect of OA. It was

Maxillary expansion for adult OSA

29

29

reported that the non-responders to OAs have higher nasal
25

resistance than the responders. Thus, nasal obstruction
should be treated before using OA.
OA has been suggested for patients with mild (SIGN
30

guideline ) to moderate OSA and for those who cannot
tolerate CPAP therapy or prefer alternate therapy.

31,32,33

OA
31

has also been recommended to alleviate simple snoring.
31

The mean reduction in AHI by OA was 13.60 events/h.

Maxillary expansion

34

A high-arched palate is a risk factor for OSA.

44

45

Maxillary expansion can also help adult patients
reduce AHI and OSA symptoms.

35

However, an adult

maxillary bone has ceased the growth and the midpalatal
suture is closed. Thus, RME achieves only dental expansion
in adults and does not effectively enlarge the palatal bone.
Therefore, it has traditionally been possible to rely on
surgically assisted rapid palatal expansion (SARPE) to
achieve maxillary expansion in adults. SARPE improves
transverse discrepancy with a tooth-borne expander with

The

palate is the roof of the mouth and the floor of the nasal

horizontal and vertical osteotomy. It also improves OSA
46

symptoms and decreases AHI by 56%.

cavity. A high-arched palate represents a narrow nasal

The tooth-borne expander of SARPE acts on the

cavity (increased nasal resistance) and a narrow dental

teeth, which renders the device's force unable to be

arch (decreased space for the tongue). Increased nasal

directly transmitted to the midpalatal suture. This in turn

resistance and a lack of palatal space for the tongue result

causes side effects from the dental expansion, resulting in

in oral breathing and low tongue posture.

a relapse rate of SARPE of up to 64%.

35

Ultimately,

the downward and backward displacement of the tongue
35

indirectly causes retrolingual obstruction.

Maxillary expansion is primarily used to improve
Taiwanese Journal of Orthodontics. 2020, Vol. 32. No. 1
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Maxillary expansion by distraction osteogenesis is
a technique involving the use of a bone-borne expander
with horizontal and vertical osteotomy. Mini-implants are

19
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placed in the maxillary bone along the midpalatal suture

target the site of anatomical obstruction, thus avoiding

to deliver the force exerted by the expander, and Le Fort

wide range of surgery.

I osteotomy and vertical osteotomy are subsequently
performed to open the midpalatal suture and reduce the
48

resistance of maxillary expansion.

Miniscrew-assisted RPE (MARPE) is another nonsurgical treatment option involving the complete or partial
use of a bone-borne expander. Bone screws are used to
deliver force directly from the expander to the maxillary
bone to split the midpalatal suture. MARPE has been
reported to expand the nasal cavity and the upper half
of the pharynx, thus reducing upper airway resistance.
Therefore, MARPE may also be an effective treatment
49

option for OSA. The success rate of MARPE for young
adults range from 84.2% (mean age= 20.1 years)
51

50

to

86.96% (mean age = 20.9 years). However, the failure
rate seems to increase with age, it’s about 15% in the
52

patients’ 20s and 50% in the 30s.

Phase I surgery

Conservative operation on soft tissue does not change

the patient's facial bones or the occlusion. Table 2 illustrates
the surgery for each upper airway obstruction site.
The overall success rate of phase I surgery is 61%,
ranging from 42% to 75% depending on the severity of
6,53

the disorder.

Phase II surgery

After phase I surgery, the obstruction of the

retrolingual area (base of the tongue) may still not be
completely treated. Subsequent treatment options can be
phase II surgery or other alternative treatment modalities
6

including tracheotomy, nasal CPAP, and OA.
The second stage of surgery involves maxillomandibular
advancement osteotomy, which reduces the collapse of
the retrolingual airway by creating more space for the

Surgical treatment

6

tongue in the oral cavity; tongue reduction can be used as

The Powell–Riley surgical protocol is a logical two6

6

adjuvant therapy.

phase surgical treatment protocol for OSA. This protocol

The success rate of phase II surgery is more than

emphasizes the need to clearly diagnose the obstruction

90%, whereas the success rate of phase II surgery that is

site of the upper airway. Surgery can be performed to

subsequent to phase I treatment is more than 95%.

53

44

Table 2. Conservative surgery for each obstruction site.

20

Obstruction site

Phase I surgery

Nasal

Septoplasty, turbinate reduction, nasal valve grafting masses

Retropalatal

Tonsillectomy, uvulopalatopharyngoplasty (UPPP) or
uvulopalatal flap (UPF)

Retrolingual

Genioglossus advancement, hyoid myotomy and suspension
of hyoid
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CONCLUSION
Many treatment options are available for OSA.
However, no treatment solution covers every situation.
Detailed diagnosis and clear identification of the upper
airway obstruction guide the choice of correct treatment.
Basing on severity, OA can be selected as the firstline treatment for mild OSA. For patients with moderate
to severe OSA, the first-line of treatment is CPAP. Surgery
can be used to treat the patients who have more severe
OSA, poor response to previous treatment, or are unable
to cope with conservative treatment.
With regard to the patient's airway obstruction
site, CPAP and weight loss are not site-specific
treatment options, OAs are more effective for patients
with retrolingual obstruction. Palatal expansion can
help to reduce the nasal resistance. Surgical treatment
should be administered according to the site of airway
obstruction, thus improving airway anatomy with a
good therapeutic effect.
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